Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Gyre Therapeutics, Inc.
Business Segments
Business Segments
Interest Income Expense Net
Interest Income Expense Net
Gyre Therapeutics, Inc.
·
Business Segments
·
2 segments
·
Rolls up to
Net Interest Income
Breakdown
Segments
Gyre Pharmaceuticals
View metric
Gyre
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q2 '25
Q2 '26
Gyre
—
—
$58K
$58K
$58K
$58K
$670K
$488K
Gyre Pharmaceuticals
$261K
$261K
$330.25K
$330.25K
$330.25K
$330.25K
$271K
$252K
Total
$283K
$326K
$328K
$350K
$523K
$346K
$941K
$740K